DR. KATHLEEN ELIZABETH PRATT, N.D.
Dietitian and Nutritionist at Leary Way, Seattle, WA
License number
Washington NT00001158
Category
Naturopathic
Type
Naturopath
Address
Address
4208 Leary Way NW, Seattle, WA 98107
Phone
(425) 270-7527
(206) 770-6294 (Fax)
(206) 770-6294 (Fax)
Personal information
See more information about KATHLEEN ELIZABETH PRATT at radaris.comName
Address
Phone
4819 161St Pl SW, Edmonds, WA 98026
910 Holm Ave, Montesano, WA 98563
1114 Arthur St, Aberdeen, WA 98520
215 10Th Ave SE, Olympia, WA 98501
910 Holm Ave, Montesano, WA 98563
Professional information
See more information about KATHLEEN ELIZABETH PRATT at trustoria.com
Kathleen Pratt, Seattle WA
Kathleen Pratt, Seattle WA
Specialties:
Primary Care Doctor
Address:
6135 Seaview Ave., Seattle, WA 98107
1221 Madison St., Seattle, WA 98104
751 Ne Blakely Dr., Issaquah, WA 98029
1221 Madison St., Seattle, WA 98104
751 Ne Blakely Dr., Issaquah, WA 98029
Education:
Bastyr University
Languages:
English
Awards and Publications:
US Rowing
About:
Dr. Pratt has been a full-time naturopathic physician with Northwest Natural Health in Seattle since 2006. She focuses on Women’s Health research as well as oncology and cardiology.
Kathleen E Pratt, Seattle WA - ND (Doctor of Naturopathic Medicine)
Kathleen E Pratt, Seattle WA - ND (Doctor of Naturopathic Medicine)
Specialties:
Naturopathy
Address:
Northwest Nat Hlth Spec Cr Clin
6135 Seaview Ave NW SUITE 300, Seattle 98107
(425) 454-8541 (Phone)
6135 Seaview Ave NW SUITE 300, Seattle 98107
(425) 454-8541 (Phone)
Languages:
English
Crystal Of A Truncated Protein Construct Containing A Coagulation Factor Viii C2 Domain In The Presence Or Absence Of A Bound Ligand And Methods Of Use Thereof
Crystal Of A Truncated Protein Construct Containing A Coagulation Factor Viii C2 Domain In The Presence Or Absence Of A Bound Ligand And Methods Of Use Thereof
US Patent:
2006029, Dec 28, 2006
Filed:
Jan 19, 2006
Appl. No.:
11/336487
Inventors:
Barry Stoddard - Bellevue WA, US
Kathleen Pratt - Seattle WA, US
Kazuo Fujikawa - Seattle WA, US
Earl Davie - Bellevue WA, US
Kathleen Pratt - Seattle WA, US
Kazuo Fujikawa - Seattle WA, US
Earl Davie - Bellevue WA, US
International Classification:
C07K 14/745, G06F 19/00
US Classification:
530383000, 702019000
Abstract:
A detailed three-dimensional structure for the C-terminal C2 domain of blood coagulation factor VIII is disclosed. The novel truncated factor VIII constructs which were designed so as to omit a significant portion of the flexible full length protein are also part of the present invention. In addition, the crystals of the protein, both in the presence and absence of bound ligands are also included. Furthermore, methods of identifying antagonists of the human factor VIII protein which can be used to inhibit coagulation or to stabilize and activate factor VIII mutants are also disclosed. Furthermore, methods of identifying variations of the C2 domain sequence and structure that can be incorporated into intact factor VIII for the purpose Of administration to hemophiliac patients who are immunoreactive against wild type factor VIII are disclosed.
Factor Viii T Cell Epitope Variants Having Reduced Immunogenicity
Factor Viii T Cell Epitope Variants Having Reduced Immunogenicity
US Patent:
2013012, May 16, 2013
Filed:
Nov 15, 2010
Appl. No.:
13/509508
Inventors:
Kathleen Pratt - Seattle WA, US
Ruth Ettinger - Seattle WA, US
Eddie Arthur James - Monroe WA, US
Ruth Ettinger - Seattle WA, US
Eddie Arthur James - Monroe WA, US
International Classification:
C07K 14/755
US Classification:
514 141, 530383, 536 235, 4353201, 435 696, 43525233
Abstract:
Provided herein are methods and compositions for preventing or reducing an initial immune response to factor VIII in patients suffering from hemophilia A, and for reducing the intensity of the immune response in patients having pre-formed inhibitor antibodies against factor VIII.
Factor Viii B Cell Epitope Variants Having Reduced Immunogenicity
Factor Viii B Cell Epitope Variants Having Reduced Immunogenicity
US Patent:
2013011, May 9, 2013
Filed:
Nov 15, 2010
Appl. No.:
13/509506
Inventors:
Kathleen Pratt - Seattle WA, US
Ruth Ettinger - Seattle WA, US
Eddie Arthur James - Monroe WA, US
Ruth Ettinger - Seattle WA, US
Eddie Arthur James - Monroe WA, US
International Classification:
A61K 38/37, C07K 14/755
US Classification:
514 141, 530383, 536 235, 4353201, 435 696, 43525233, 43525421, 43525411, 435348, 435419, 435366, 435325
Abstract:
Provided herein are methods and compositions for preventing or reducing an initial immune response to factor VIII in patients suffering from hemophilia A, and for reducing the intensity of the immune response in patients having pre-formed inhibitor antibodies against factor VIII.